Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In recent years, long noncoding RNAs (lncRNAs) have been reported to have significant regulating effect in human cancer development. Previous studies suggested that dysregulation of lncRNA 441178 (
LOC441178
) is possibly associated with oral squamous cell carcinoma (OSCC). The postoperative survival time was significantly prolonged in the high-grade OSCC patients with high
LOC441178
expression compared with those with low
LOC441178
expression, which indicated that
LOC441178
may act as a prognostic marker and as a potential tumor suppressor for OSCC. However, the biological molecular mechanisms behind these phenomena remain almost unknown. Here, our studies revealed that
LOC441178
suppressed the invasion and migration of squamous carcinoma cells (SCCs). Furthermore, we found that rho-associated, coiled-coil-containing
protein kinase
1 (ROCK1) is one of the functionally relevant targets of
LOC441178
in squamous cells, which is negatively correlated with
LOC441178
in tumor tissues from OSCC patients. In conclusion, our findings demonstrated the inhibition effect of
LOC441178
on tumor in OSCC and might have potential implications for OSCC gene therapy. In conclusion, these results suggest that
LOC441178
could represent a prognostic indicator for OSCC and be a new target for the diagnosis and treatment of OSCC.
...
PMID:Long Noncoding RNA LOC441178 Reduces the Invasion and Migration of Squamous Carcinoma Cells by Targeting ROCK1. 3036 63